BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kip E, Parr-Brownlie LC. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease. Ageing Res Rev 2022;78:101618. [PMID: 35395416 DOI: 10.1016/j.arr.2022.101618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Pini L, Salvalaggio A, Wennberg AM, Dimakou A, Matteoli M, Corbetta M. The pollutome-connectome axis: a putative mechanism to explain pollution effects on neurodegeneration. Ageing Res Rev 2023;86:101867. [PMID: 36720351 DOI: 10.1016/j.arr.2023.101867] [Reference Citation Analysis]
2 Wu Y, Wang W, Qiu X, Lu Z, Ji W, Shen J, Peng H, Zhao R, Wang J, Zhang T, Yang J, Zhang X. A STIR nucleic acid drug delivery system for stirring phenotypic switch of microglia in Parkinson’s disease treatments. Nano Res 2023. [DOI: 10.1007/s12274-022-5353-5] [Reference Citation Analysis]
3 Wang X, Hao X, Yan J, Xu J, Hu D, Ji F, Zeng T, Wang F, Wang B, Fang J, Ji J, Luan H, Hong Y, Zhang Y, Chen J, Li M, Yang Z, Zhang D, Liu W, Cai X, Cai Z. Urine biomarkers discovery by metabolomics and machine learning for Parkinson's disease diagnoses. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108230] [Reference Citation Analysis]
4 Kulkarni A, Preeti K, Tryphena KP, Srivastava S, Singh SB, Khatri DK. Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics. Ageing Res Rev 2023;84:101816. [PMID: 36481490 DOI: 10.1016/j.arr.2022.101816] [Reference Citation Analysis]
5 Lin MS, Wang YC, Chen WJ, Kung WM. Impact of gut–brain interaction in emerging neurological disorders. World J Clin Cases 2023; 11(1): 1-6 [PMID: 36687174 DOI: 10.12998/wjcc.v11.i1.1] [Reference Citation Analysis]
6 Kip E, Parr-Brownlie LC. Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders. Front Neurosci 2023;17:1092537. [PMID: 36875655 DOI: 10.3389/fnins.2023.1092537] [Reference Citation Analysis]
7 Muslikh FA, Samudra RR, Ma’arif B, Ulhaq ZS, Hardjono S, Agil M. In Silico Molecular Docking and ADMET Analysis for Drug Development of Phytoestrogens Compound with Its Evaluation of Neurodegenerative Diseases. Borneo J Pharm 2022;5:357-366. [DOI: 10.33084/bjop.v5i4.3801] [Reference Citation Analysis]
8 Yan YC, Xu ZH, Wang J, Yu WB. Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease. Front Pharmacol 2022;13:1007556. [PMID: 36249800 DOI: 10.3389/fphar.2022.1007556] [Reference Citation Analysis]
9 Guan Q, Liu W, Mu K, Hu Q, Xie J, Cheng L, Wang X. Single-cell RNA sequencing of CSF reveals neuroprotective RAC1+ NK cells in Parkinson’s disease. Front Immunol 2022;13:992505. [DOI: 10.3389/fimmu.2022.992505] [Reference Citation Analysis]
10 Wang Y, Wu S, Li Q, Lang W, Li W, Jiang X, Wan Z, Chen J, Wang H. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease. Front Pharmacol 2022;13:977521. [DOI: 10.3389/fphar.2022.977521] [Reference Citation Analysis]
11 Banstola A, Reynolds JNJ. The Sheep as a Large Animal Model for the Investigation and Treatment of Human Disorders. Biology 2022;11:1251. [DOI: 10.3390/biology11091251] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Shen Y, Qian L, Luo H, Li X, Ruan Y, Fan R, Si Z, Chen Y, Li L, Liu Y. The Significance of NLRP Inflammasome in Neuropsychiatric Disorders. Brain Sciences 2022;12:1057. [DOI: 10.3390/brainsci12081057] [Reference Citation Analysis]
13 Zhuang J, Jia J. Effects of Respiratory Muscle Strength Training on Respiratory-Related Impairments of Parkinson's Disease. Front Aging Neurosci 2022;14:929923. [DOI: 10.3389/fnagi.2022.929923] [Reference Citation Analysis]
14 Angelopoulou E, Bougea A, Papageorgiou SG, Villa C. Psychosis in Parkinson's Disease: A Lesson from Genetics. Genes (Basel) 2022;13:1099. [PMID: 35741861 DOI: 10.3390/genes13061099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shkodina A, Iengalychev T, Tarianyk K, Boiko D, Lytvynenko N, Skrypnikov A. Relationship between sleep disorders and neuropsychiatric symptoms in Parkinson's disease: A narrative review. Acta fac medic Naissensis 2022;39:259-274. [DOI: 10.5937/afmnai39-33652] [Reference Citation Analysis]